Remy Froissart, CNRS

Outils pour utilisateurs

Outils du site

Vous êtes ici: start
Piste:
start

Différences

Ci-dessous, les différences entre deux révisions de la page.

Lien vers cette vue comparative

Les deux révisions précédentes Révision précédente
Prochaine révision 		Révision précédente
start [2024/10/23 15:41]
remyfroissart [Articles] 		start [2025/06/17 21:04] (Version actuelle)
remyfroissart [Articles]
Ligne 28: Ligne 28:
 In 2014, I decided to come back on phage'evolution through a collaboration with [[ http://www.idm.uct.ac.za/Jo-Ann_Passmore|Jo-Ann Passmore]] (University of Cape-Town, South-Africa), [[ https://virostyle.cnrs.fr/team/ignacio-bravo/|Ignacio Bravo]] (MIVEGEC, Montpellier, France) and [[ https://marievasse.eu/|Marie Vasse]] (post-doc, MIVEGEC, Marie-Curie grant) with whom we are working on disturbance of microbial vaginal ecosystem that may results on dysbiosis (in particular, bacterial vaginosis).  In 2014, I decided to come back on phage'evolution through a collaboration with [[ http://www.idm.uct.ac.za/Jo-Ann_Passmore|Jo-Ann Passmore]] (University of Cape-Town, South-Africa), [[ https://virostyle.cnrs.fr/team/ignacio-bravo/|Ignacio Bravo]] (MIVEGEC, Montpellier, France) and [[ https://marievasse.eu/|Marie Vasse]] (post-doc, MIVEGEC, Marie-Curie grant) with whom we are working on disturbance of microbial vaginal ecosystem that may results on dysbiosis (in particular, bacterial vaginosis). 
  
-I also work with [[ https://isem-evolution.fr/membre/martin/|Guillaume Martin]] (CNRS, ISEM, Montpellier, France) and [[ https://www.researchgate.net/profile/Yoann-Anciaux|Yoann Anciaux]] (post-doc ISEM-MIVEGEC, Montpellier, France) on //in vitro// evolutionary rescue of bacteria stressed by antibiotics and/or bacteriophages targetting //E.coli//. I also participate to the project [[ https://www.chu-lyon.fr/antibioresistance-projet-phag-one|Phag-One]] leaded by Frederic Laurent and Tristan Ferry ([[ https://www.crioac-lyon.fr/phagotherapie-bacteriophage/|Hospice Civile de Lyon]]) on the bacteriophage' host-range targetting //Staphylococcus epidermidis// and //E.coli//. Finally, I'm currently also working on //Salmonella// 'bacteriophages in order to perform long-term efficiency of bacteriophage biocontrol. +I also work with [[ https://isem-evolution.fr/membre/martin/|Guillaume Martin]] (CNRS, ISEM, Montpellier, France) on //in vitro// evolutionary rescue of bacteria stressed by antibiotics and/or bacteriophages targetting //E.coli//. I also participate to the project [[ https://www.chu-lyon.fr/antibioresistance-projet-phag-one|Phag-One]] leaded by Frederic Laurent and Tristan Ferry ([[ https://www.crioac-lyon.fr/phagotherapie-bacteriophage/|Hospice Civile de Lyon]]) on the bacteriophage' host-range targetting //Staphylococcus epidermidis// and //E.coli//. Finally, I'm currently also working on //Salmonella// 'bacteriophages in order to perform long-term efficiency of bacteriophage biocontrol.  
 + 
 +===== Areas of expertise ===== 
 +  * evolutionary virology 
 +  * experimental evolution 
 +  * adaptation 
 +  * evolution in heterogeneous environment (spatial / temporal heterogeneity) 
 +  * evolution towards specialisation / generalism 
 +  * phage therapy and biocontrol
  
 ====== Collective scientific responsabilities ====== ====== Collective scientific responsabilities ======
Ligne 44: Ligne 52:
   * Elected representant to the logistic group of MIVEGEC (2018- )   * Elected representant to the logistic group of MIVEGEC (2018- )
   * Scientific responsible for the laboratory security (level L2) of MIVEGEC (2016- )   * Scientific responsible for the laboratory security (level L2) of MIVEGEC (2016- )
-  * APA Correspondant (Nagoya protocol) for MIVEGEC (2021- ) 
   * Participant of the Science ecological councern group of MIVEGEC (MIVEGEC-1.5)   * Participant of the Science ecological councern group of MIVEGEC (MIVEGEC-1.5)
  
Ligne 60: Ligne 67:
   * **Post-doctoral position in Hopital Bichat** 2003-2004 (Group « Ecologie et évolution des micro-organismes » in collaboration with O. Tenaillon & E. Denamur, Institut National de la Santé et de la Recherche Médicale (INSERM) Paris, France)   * **Post-doctoral position in Hopital Bichat** 2003-2004 (Group « Ecologie et évolution des micro-organismes » in collaboration with O. Tenaillon & E. Denamur, Institut National de la Santé et de la Recherche Médicale (INSERM) Paris, France)
   * **Post-doctoral position in Yale University** 2002-2003 (Paul Turner’ group in Yale University, New-Haven, USA)   * **Post-doctoral position in Yale University** 2002-2003 (Paul Turner’ group in Yale University, New-Haven, USA)
-  * **PhD in Biology** 2002 (« Experimental study of the evolution of the mechanism of transmission of the Cauliflower mosaic virus ». Pierre-et-Marie-Curie University, PhD defense on may 6th, 2002.+  * **PhD in Biology** 2002 (« Experimental study of the evolution of the mechanism of transmission of the //Cauliflower mosaic virus// » ([[https://theses.hal.science/tel-04981558|manuscript pdf here]]). Pierre-et-Marie-Curie University, PhD defense on may 6th, 2002.
   * **DEA  « Biologie, Diversité, adaptation des plantes cultivées »** 1998 (Institut National d’Agronomie INA-PG – Universités de Paris VI et Paris XI, Ecole Nationale Supérieure Agronomique de Montpellier ENSAM)   * **DEA  « Biologie, Diversité, adaptation des plantes cultivées »** 1998 (Institut National d’Agronomie INA-PG – Universités de Paris VI et Paris XI, Ecole Nationale Supérieure Agronomique de Montpellier ENSAM)
   * **Maîtrise (option Evolution & génétique)** 1997 (Université de Montpellier II)   * **Maîtrise (option Evolution & génétique)** 1997 (Université de Montpellier II)
Ligne 71: Ligne 78:
 °  Authors contributed equally to the work °  Authors contributed equally to the work
 # corresponding author(s) # corresponding author(s)
 +
 +
 +===2025===
 +  * Maurin A., C. Zarate-Chaves, C. Breyton, J. Dainat, A. Feugier & R. Froissart. 2025. « [[https://www.biorxiv.org/cgi/content/short/2025.06.16.659957v1|The complete genome and comparative analysis of a new Tequintavirus: Salmonella phage Tennessee Salten]] ». **BioRxiv**
  
 ===2024=== ===2024===
   * Brives C, R. Froissart, B. Perez-Sepulveda & C. Le Marrec. 2024. « [[https://doi.org/10.1089/phage.2023.0047|Thinking Phage Innovations Through Evolution and Ecology]] ». **PHAGE** 5(1)   * Brives C, R. Froissart, B. Perez-Sepulveda & C. Le Marrec. 2024. « [[https://doi.org/10.1089/phage.2023.0047|Thinking Phage Innovations Through Evolution and Ecology]] ». **PHAGE** 5(1)
-  * Maurin A., M. Vasse, C. Breyton, C. Zarate-Chaves, S. Bouzidi, J. Hayer, J. Dainat, Margaux Mesleard-Roux, F-X. Weill, I. G. Bravo, A. Feugier & R. Froissart. 2024. « [[https://doi.org/10.1101/2024.03.13.584857|“This training is bound for glory” : selection by experimental evolution of a bacteriophage with expanded host-range and increased virulence]]. BioRxiv+  * Maurin A., M. Vasse, C. Breyton, C. Zarate-Chaves, S. Bouzidi, J. Hayer, J. Dainat, Margaux Mesleard-Roux, F-X. Weill, I. G. Bravo, A. Feugier & R. Froissart. 2024. « [[https://doi.org/10.1101/2024.03.13.584857|“This training is bound for glory” : selection by experimental evolution of a bacteriophage with expanded host-range and increased virulence]] ». **BioRxiv**
  
 ===2022=== ===2022===
start.1729690907.txt.gz · Dernière modification: 2024/10/23 15:41 de remyfroissart

Outils de la page

Sauf mention contraire, le contenu de ce wiki est placé sous les termes de la licence suivante : CC Attribution-Noncommercial-Share Alike 4.0 International
CC Attribution-Noncommercial-Share Alike 4.0 International Donate Powered by PHP Valid HTML5 Valid CSS Driven by DokuWiki